Article

Design of Experiments (DoE)-Based Optimization of Pomalidomide Nanosuspension for Improved Oral Absorption and Pharmacokinetics

Shaik Sabiha Thabbssum1, Darna Bhikshapathi2★, Pavan Kumar Jaini3, Medipally Viswaja2, Mohammed Apsar Pasha4★ Corresponding author

  1. 1Department of Pharmacy, Bir Tikandrajit University, Canchipur, Imphal west, Manipur, INDIA.
  2. 2Department of Pharmaceutics, Teegala Ram Reddy College of Pharmacy, Meerpet, Hyderabad, Telangana, INDIA.
  3. 3Department of Pharmacy, Raffles University, Neemrana, Rajasthan, INDIA.
  4. 4Department of Pharmacy, Motherhood University, Roorkee, Uttarakhand, INDIA.

CORRESPONDENCE

Darna Bhikshapathi

Department of Pharmaceutics, Teegala Ram Reddy College of Pharmacy, Meerpet, Hyderabad, Telangana, INDIA.

dbpathi71@gmail.com

Received: 09-01-2026; Revised: 23-02-2026; Accepted: 16-04-2026.

Volume 60, Issue 3S · pp. s1024–s1036 · PUBLISHED 2026 · DOI: 10.5530/ijper.20262826

View on IJPER original site ↗

ABSTRACT

Aim: The study aims to enhance the oral bioavailability and solubility of Pomalidomide (POM), which is classified as a class IV medication based on the Biopharmaceutical Classification System (BCS). Materials and Methods: A POM Nanosuspension (NS) was developed using a high-pressure homogenizer. The selection of stabilizers was initially done using a One-Factor-at-A-Time (OFAT) method, considering both PdI and Particle Size (PS). A Box-Behnken Design (BBD) with 3 factors and 3 levels was employed in 17 experimental trials to study how stabilizer concentration, cycle count, and pressure impact Zeta Potential (ZP) and PS. The combination of Soluplus® and Hydroxypropyl Methylcellulose (HPMC) was identified as the optimal stabilizer mix. Results: The resulting NS displayed a reduced PS of 132.9 nm and a ZP of -22.9 mV. SEM images showed that the particles were spherical. Further investigation with FT-IR, DSC, and X-ray Diffraction (XRD) studies substantiated the compatibility and alteration of POM into an amorphous state. The optimized POM-NS demonstrated a 21.56-fold increase in solubility, with more than 97% drug release within the first hour. The formulation also showed a 2.14-fold increase in Cmax and a 1.56-fold increase in AUC0-t. Conclusion: The modified POM NS markedly improved solubility, oral absorption, and bioavailability, indicating its potential for higher therapeutic efficacy.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Thabbssum, S. S., Bhikshapathi, D., Jaini, P. K., Viswaja, M., & Pasha, M. A. (2026). Design of Experiments (DoE)-Based Optimization of Pomalidomide Nanosuspension for Improved Oral Absorption and Pharmacokinetics. Indian Journal of Pharmaceutical Education and Research, 60(3S), s1024–s1036. https://doi.org/10.5530/ijper.20262826